IMCR
Immunocore AmericanFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
IMCR vs peer average
15/100
IMCR vs. peer average (F vs. C)
Grade spread
A 2 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
PVLA is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.5B
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMCR
Immunocore American
PVLA
Palvella Therapeutics
Grade
F
C
Momentum
25
51
Value
48
41
Sentiment
-
70
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs PVLA
IMCR / PVLA
Grade Position
Below peers
IMCR vs. peer average (F vs. C)
15/100
Momentum
25
PVLAValue
48
IMCRSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMCR
PVLA is the first peer returned for this comparison set.

